Adimab Collaborator GSK Receives Additional Marketing Approval for Depemokimab
Adimab Collaborator GSK has received additional marketing approval for depemokimab, marking the sixth collaborator program to reach the market and strengthening its biologics portfolio.
Adimab Collaboration Biologics | 17/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy